Kazia Therapeutics (KZIA) Enterprise Value Growth (1y) (2010 - 2025)
Kazia Therapeutics (KZIA) Enterprise Value Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,011.97 Bn | 67,011.68 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.88 Bn | 467.08 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.20 Bn | 114.96 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.17 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.85 Bn | 50.67 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Kazia Therapeutics | 19.29 Bn | 19.29 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,262.38% |
| Jun 30, 2025 | -148.36% |
| Dec 31, 2024 | -46.26% |
| Jun 30, 2024 | 68.02% |
| Dec 31, 2023 | 21.51% |
| Jun 30, 2023 | 33.56% |
| Dec 31, 2022 | 73.93% |
| Jun 30, 2022 | 79.91% |
| Dec 31, 2021 | 44.68% |
| Jun 30, 2021 | -146.24% |
| Dec 31, 2020 | -367.08% |
| Jun 30, 2020 | -180.05% |
| Dec 31, 2019 | -55.85% |
| Jun 30, 2019 | 15.58% |
| Jun 30, 2018 | 58.48% |
| Jun 30, 2017 | 56.53% |
| Dec 31, 2016 | 84.51% |
| Jun 30, 2016 | 28.08% |
| Dec 31, 2015 | -1,149.12% |
| Jun 30, 2015 | -1,243.12% |